These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 9135277

  • 1. Liver toxicity in a nephrotic patient treated with levamisole.
    Bulugahapitiya DT.
    Arch Dis Child; 1997 Mar; 76(3):289. PubMed ID: 9135277
    [No Abstract] [Full Text] [Related]

  • 2. Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome.
    Barbano G, Ginevri F, Ghiggeri GM, Gusmano R.
    Pediatr Nephrol; 1999 Sep; 13(7):602-3. PubMed ID: 10460511
    [Abstract] [Full Text] [Related]

  • 3. Levamisole Induced Agranulocytosis in a Child with Steroid Dependent Nephrotic Syndrome: A Case Report.
    Anjum MF, Gupta GK, Bhandari J.
    JNMA J Nepal Med Assoc; 2024 Jul 31; 62(276):545-547. PubMed ID: 39369404
    [Abstract] [Full Text] [Related]

  • 4. Distinctive vasculopathy with systemic involvement due to levamisole long-term therapy: a case report.
    Aoun B, Alali M, Degheili JA, Sanjad S, Vaquin C, Donadieu J, Ulinski T, Termos S.
    J Med Case Rep; 2018 Jul 16; 12(1):209. PubMed ID: 30008268
    [Abstract] [Full Text] [Related]

  • 5. Ear lobe bilateral necrosis by levamisole-induced occlusive vasculitis in a pediatric patient.
    Menni S, Pistritto G, Gianotti R, Ghio L, Edefonti A.
    Pediatr Dermatol; 1997 Jul 16; 14(6):477-9. PubMed ID: 9436850
    [Abstract] [Full Text] [Related]

  • 6. Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children.
    Rongioletti F, Ghio L, Ginevri F, Bleidl D, Rinaldi S, Edefonti A, Gambini C, Rizzoni G, Rebora A.
    Br J Dermatol; 1999 May 16; 140(5):948-51. PubMed ID: 10354040
    [Abstract] [Full Text] [Related]

  • 7. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.
    Gruppen MP, Bouts AH, Jansen-van der Weide MC, Merkus MP, Zurowska A, Maternik M, Massella L, Emma F, Niaudet P, Cornelissen EAM, Schurmans T, Raes A, van de Walle J, van Dyck M, Gulati A, Bagga A, Davin JC, all members of the Levamisole Study Group.
    Kidney Int; 2018 Feb 16; 93(2):510-518. PubMed ID: 29054532
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation of the efficacy of levamisole in corticosteroid-dependent nephrotic syndrome in children].
    Ksiazek J, Kryński J.
    Pediatr Pol; 1995 Dec 16; 70(12):1037-42. PubMed ID: 8649943
    [Abstract] [Full Text] [Related]

  • 9. Levamisole therapy in nephrotic syndrome.
    Srivastava RN.
    Pediatr Nephrol; 1999 Sep 16; 13(7):636. PubMed ID: 10507834
    [No Abstract] [Full Text] [Related]

  • 10. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
    Alsaran K, Grisaru S, Stephens D, Arbus G.
    Clin Nephrol; 2001 Oct 16; 56(4):289-94. PubMed ID: 11680658
    [Abstract] [Full Text] [Related]

  • 11. Protracted levamisole in children with frequent-relapse nephrotic syndrome.
    Ginevri F, Trivelli A, Ciardi MR, Ghiggeri GM, Parfumo F, Gusmano R.
    Pediatr Nephrol; 1996 Aug 16; 10(4):550. PubMed ID: 8865269
    [No Abstract] [Full Text] [Related]

  • 12. [Levamisole in the treatment of nephrotic syndrome].
    García Soto L, Miranda Romera P, Vintimilla Andrade JE, Gómez Llorente MA, de Diego Fernández P.
    An Pediatr (Engl Ed); 2020 Mar 16; 92(3):168-169. PubMed ID: 31151760
    [No Abstract] [Full Text] [Related]

  • 13. Onset of leukaemia after levamisole treatment for nephrotic syndrome.
    Mackie FE, Roy LP, Stevens M.
    Pediatr Nephrol; 1994 Aug 16; 8(4):527-8. PubMed ID: 7947054
    [No Abstract] [Full Text] [Related]

  • 14. Is there a contraindication for polio vaccination in children who are treated with levamisole?
    Blanche S.
    Pediatr Nephrol; 2000 Sep 16; 14(10-11):1059. PubMed ID: 10975326
    [No Abstract] [Full Text] [Related]

  • 15. Effect of levamisole in steroid-dependent nephrotic syndrome.
    Madani A, Isfahani ST, Rahimzadeh N, Fereshtehnejad SM, Hoseini R, Moghtaderi M, Mohseni P, Ataiee N.
    Iran J Kidney Dis; 2010 Oct 16; 4(4):292-6. PubMed ID: 20852369
    [Abstract] [Full Text] [Related]

  • 16. Side effects of levamisole in children with nephrosis.
    Palcoux JB, Niaudet P, Goumy P.
    Pediatr Nephrol; 1994 Apr 16; 8(2):263-4. PubMed ID: 8018513
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.
    Abeyagunawardena AS, Karunadasa U, Jayaweera H, Thalgahagoda S, Tennakoon S, Abeyagunawardena S.
    Pediatr Nephrol; 2017 Aug 16; 32(8):1363-1367. PubMed ID: 28299461
    [Abstract] [Full Text] [Related]

  • 18. Population pharmacokinetics of levamisole in children with steroid-sensitive nephrotic syndrome.
    Kreeftmeijer-Vegter AR, Dorlo TP, Gruppen MP, de Boer A, de Vries PJ.
    Br J Clin Pharmacol; 2015 Aug 16; 80(2):242-52. PubMed ID: 25677380
    [Abstract] [Full Text] [Related]

  • 19. Levamisole in steroid-sensitive nephrotic syndrome: usefulness in adult patients and laboratory insights into mechanisms of action via direct action on the kidney podocyte.
    Jiang L, Dasgupta I, Hurcombe JA, Colyer HF, Mathieson PW, Welsh GI.
    Clin Sci (Lond); 2015 Jun 16; 128(12):883-93. PubMed ID: 25626449
    [Abstract] [Full Text] [Related]

  • 20. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
    Kemper MJ, Amon O, Timmermann K, Altrogge H, Müller-Wiefel DE.
    Dtsch Med Wochenschr; 1998 Feb 27; 123(9):239-43. PubMed ID: 9524533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.